"Metabolic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Descriptor ID |
D008659
|
| MeSH Number(s) |
C18.452
|
| Concept/Terms |
Metabolic Diseases- Metabolic Diseases
- Thesaurismosis
- Thesaurismoses
- Diseases, Metabolic
- Disease, Metabolic
- Metabolic Disease
|
Below are MeSH descriptors whose meaning is more general than "Metabolic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Metabolic Diseases".
This graph shows the total number of publications written about "Metabolic Diseases" by people in this website by year, and whether "Metabolic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 0 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 3 | 1 | 4 |
| 2011 | 3 | 1 | 4 |
| 2012 | 1 | 4 | 5 |
| 2013 | 2 | 0 | 2 |
| 2014 | 4 | 1 | 5 |
| 2015 | 7 | 3 | 10 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 5 | 1 | 6 |
| 2019 | 4 | 2 | 6 |
| 2020 | 4 | 2 | 6 |
| 2021 | 2 | 1 | 3 |
| 2022 | 3 | 1 | 4 |
| 2023 | 4 | 1 | 5 |
| 2024 | 2 | 2 | 4 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metabolic Diseases" by people in Profiles.
-
Burden of cardiometabolic diseases and depression in a low-income, urban community in Pakistan: a cross-sectional survey. BMC Public Health. 2025 Feb 24; 25(1):757.
-
Current Burden of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults, 2017-2023. Aliment Pharmacol Ther. 2025 Mar; 61(5):891-894.
-
Age-related TFEB downregulation in proximal tubules causes systemic metabolic disorders and occasional apolipoprotein A4-related amyloidosis. JCI Insight. 2024 Dec 19; 10(3).
-
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases. Metabolism. 2024 Oct; 159:155931.
-
Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality. J Gastroenterol Hepatol. 2024 Sep; 39(9):1950-1956.
-
Identifying potential dietary treatments for inherited metabolic disorders using Drosophila nutrigenomics. Cell Rep. 2024 03 26; 43(3):113861.
-
Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders. Sci Transl Med. 2023 11 22; 15(723):eade8460.
-
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology. 2024 05 01; 79(5):1212-1219.
-
Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States. J Hepatol. 2024 02; 80(2):e79-e81.
-
Diagnosis and management of cardiometabolic disease after spinal cord injury: Identifying gaps in physician training and practices. J Spinal Cord Med. 2025 Jan; 48(1):39-45.